Annual Cash & Cash Equivalents
$75.14 M
+$74.98 M+47456.33%
December 31, 2023
Summary
- As of February 20, 2025, SGMT annual cash & cash equivalents is $75.14 million, with the most recent change of +$74.98 million (+47456.33%) on December 31, 2023.
- During the last 3 years, SGMT annual cash & cash equivalents has risen by +$6.44 million (+9.37%).
- SGMT annual cash & cash equivalents is now at all-time high.
Performance
SGMT Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Cash And Cash Equivalents
$77.01 M
-$18.95 M-19.74%
September 30, 2024
Summary
- As of February 20, 2025, SGMT quarterly cash and cash equivalents is $77.01 million, with the most recent change of -$18.95 million (-19.74%) on September 30, 2024.
- Over the past year, SGMT quarterly cash and cash equivalents has increased by +$1.88 million (+2.50%).
- SGMT quarterly cash and cash equivalents is now -56.43% below its all-time high of $176.78 million, reached on March 31, 2024.
Performance
SGMT Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash And Cash Equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
SGMT Cash And Cash Equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +10000.0% | +2.5% |
| 3 y3 years | +9.4% | +524.2% |
| 5 y5 years | +635.8% | +524.2% |
SGMT Cash And Cash Equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | >+9999.0% | -56.4% | >+9999.0% |
| 5 y | 5-year | at high | >+9999.0% | -56.4% | >+9999.0% |
| alltime | all time | at high | >+9999.0% | -56.4% | >+9999.0% |
Sagimet Biosciences Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $77.01 M(-19.7%) |
| Jun 2024 | - | $95.96 M(-45.7%) |
| Mar 2024 | - | $176.78 M(+135.3%) |
| Dec 2023 | $75.14 M | $75.14 M(-26.2%) |
| Sep 2023 | - | $101.84 M(+450.3%) |
| Jun 2023 | - | $18.51 M(+50.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2023 | - | $12.34 M(+7708.9%) |
| Dec 2022 | $158.00 K(-99.7%) | $158.00 K(-99.8%) |
| Dec 2021 | $56.73 M(-17.4%) | - |
| Mar 2021 | - | $74.94 M |
| Dec 2020 | $68.70 M(+572.8%) | - |
| Dec 2019 | $10.21 M | - |
FAQ
- What is Sagimet Biosciences annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Sagimet Biosciences?
- What is Sagimet Biosciences annual cash & cash equivalents year-on-year change?
- What is Sagimet Biosciences quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for Sagimet Biosciences?
- What is Sagimet Biosciences quarterly cash and cash equivalents year-on-year change?
What is Sagimet Biosciences annual cash & cash equivalents?
The current annual cash & cash equivalents of SGMT is $75.14 M
What is the all time high annual cash & cash equivalents for Sagimet Biosciences?
Sagimet Biosciences all-time high annual cash & cash equivalents is $75.14 M
What is Sagimet Biosciences annual cash & cash equivalents year-on-year change?
Over the past year, SGMT annual cash & cash equivalents has changed by +$74.98 M (+47456.33%)
What is Sagimet Biosciences quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of SGMT is $77.01 M
What is the all time high quarterly cash and cash equivalents for Sagimet Biosciences?
Sagimet Biosciences all-time high quarterly cash and cash equivalents is $176.78 M
What is Sagimet Biosciences quarterly cash and cash equivalents year-on-year change?
Over the past year, SGMT quarterly cash and cash equivalents has changed by +$1.88 M (+2.50%)